Home › Companies › VOYAGER THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and VOYAGER THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 3, 2025: 8 items on VOYAGER THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025: 4 elected · 4 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VOYAGER THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VOYAGER THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Grace E. Colón, Ph.D. | 38,209,235 | -- | -- | 1,688,859 | 8,531,070 | 96% | Elected | — |
| Elect Director: Catherine J. Mackey, Ph.D. | 38,216,364 | -- | -- | 1,681,730 | 8,531,070 | 96% | Elected | — |
| Elect Director: Glenn Pierce, M.D., Ph.D. | 38,123,609 | -- | -- | 1,774,485 | 8,531,070 | 96% | Elected | — |
| Elect Director: George Scangos, Ph.D. | 33,177,695 | -- | -- | 6,720,399 | 8,531,070 | 83% | Elected | — |
| Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers. | 37,755,432 | 2,034,622 | 108,040 | -- | 8,531,070 | 95% | Approved | — |
| Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2025. | 48,137,216 | 249,172 | 42,776 | -- | -- | 99.4% | Approved | — |
| Voyager's stockholders approved the 2025 Stock Incentive Plan. | 28,582,188 | 11,275,604 | 40,302 | -- | 8,531,070 | 72% | Approved | — |
| Voyager's stockholders approved the Amended and Restated 2015 Employee Stock Purchase Plan. | 36,532,540 | 3,326,824 | 38,730 | -- | 8,531,070 | 92% | Approved | — |
Source: VOYAGER THERAPEUTICS INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.
Each item below shows how the 146 asset managers that disclosed a VOYAGER THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following nominees to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Catherine J. Mackey, Ph.D.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Catherine J. Mackey, Ph.D.”): 38,216,364 for, 1,681,730 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Grace E. Colón, Ph.D., Catherine J. Mackey, Ph.D., Glenn Pierce, M.D., Ph.D., and George Scangos, Ph.D., each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject t…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 841,759 | Withhold |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 130,899 | 0 | 0 | 0 | For |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,181 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 48,265 | 0 | 0 | 0 | For |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,100 | 0 | 0 | 5,237 | Mixed |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 33,263 | 0 | 1,361 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 0 | 0 | 12,240 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 7,935,180 for, 865,856 withheld, 11,708 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 1,116,793 | Withhold |
Institutional-manager reports, all 1 managers: 1,116,793 withheld.
Combines 4 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following nominees to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: George Scangos, Ph.D.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: George Scangos, Ph.D.”): 33,177,695 for, 6,720,399 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Grace E. Colón, Ph.D., Catherine J. Mackey, Ph.D., Glenn Pierce, M.D., Ph.D., and George Scangos, Ph.D., each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject t…”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 841,759 | Withhold |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 183,738 | Withhold |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 130,899 | Withhold |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 54,768 | 0 | 0 | 40,570 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 83,181 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 0 | 0 | 57,491 | Withhold |
| EA Series Trust | 0 | 0 | 48,265 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 0 | 44,721 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 39,337 | Withhold |
| Allspring | 0 | 0 | 0 | 38,980 | Withhold |
| John Hancock | 15,964 | 0 | 18,660 | 0 | Mixed |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 28,118 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 22,537 | Withhold |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 21,374 | Withhold |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 7,062,486 for, 1,651,748 withheld, 98,510 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,116,793 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,116,793 for.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following nominees to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Glenn Pierce, M.D., Ph.D.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Glenn Pierce, M.D., Ph.D.”): 38,123,609 for, 1,774,485 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Grace E. Colón, Ph.D., Catherine J. Mackey, Ph.D., Glenn Pierce, M.D., Ph.D., and George Scangos, Ph.D., each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject t…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 841,759 | Withhold |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 130,899 | 0 | 0 | 0 | For |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,181 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 48,265 | 0 | 0 | 0 | For |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,100 | 0 | 0 | 5,237 | Mixed |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 33,263 | 0 | 1,361 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 0 | 0 | 12,240 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 7,935,180 for, 865,856 withheld, 11,708 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,116,793 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,116,793 for.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following nominees to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Grace E. Colon, Ph.D.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Elect Director: Grace E. Colón, Ph.D.”): 38,209,235 for, 1,688,859 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(a) Voyager's stockholders elected Grace E. Colón, Ph.D., Catherine J. Mackey, Ph.D., Glenn Pierce, M.D., Ph.D., and George Scangos, Ph.D., each to serve as a Class I director until the 2028 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, subject t…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 841,759 | Withhold |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 130,899 | 0 | 0 | 0 | For |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,181 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 48,265 | 0 | 0 | 0 | For |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,100 | 0 | 0 | 5,237 | Mixed |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 33,263 | 0 | 1,361 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 0 | 0 | 12,240 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 7,935,180 for, 865,856 withheld, 11,708 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 1,116,793 | 0 | 0 | Against |
Institutional-manager reports, all 1 managers: 1,116,793 against.
Combines 2 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: To approve the Voyager Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders approved the Amended and Restated 2015 Employee Stock Purchase Plan.”): 36,532,540 for, 3,326,824 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(e) Voyager's stockholders approved the Amended and Restated 2015 Employee Stock Purchase Plan.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 841,759 | 0 | 0 | 0 | For |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 130,899 | 0 | 0 | 0 | For |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,181 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 48,265 | 0 | 0 | 0 | For |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,337 | 0 | 0 | 0 | For |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 34,624 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 12,240 | 0 | 0 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 8,800,504 for, 12,240 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,116,793 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,116,793 for.
72% Approved · of votes cast
Description as filed by funds: To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders approved the 2025 Stock Incentive Plan.”): 28,582,188 for, 11,275,604 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(d) Voyager's stockholders approved the 2025 Stock Incentive Plan.”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 6,468,068 for, 2,326,373 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 820,604 | 82,600 | 0 | 0 | Mixed |
| Dimensional | 0 | 841,759 | 0 | 0 | Against |
| T. Rowe Price | 0 | 423,498 | 0 | 0 | Against |
| MFS | 0 | 183,738 | 0 | 0 | Against |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 0 | 130,899 | 0 | 0 | Against |
| TIAA | 0 | 107,849 | 0 | 0 | Against |
| Equitable | 52,076 | 43,262 | 0 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 0 | 83,181 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 57,491 | 0 | 0 | Against |
| EA Series Trust | 48,265 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 44,721 | 0 | 0 | Against |
| Lincoln Financial | 0 | 39,337 | 0 | 0 | Against |
| Allspring | 0 | 38,980 | 0 | 0 | Against |
| John Hancock | 0 | 34,624 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 28,118 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 22,537 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 22,320 | 0 | 0 | Against |
| Brighthouse | 12,240 | 9,134 | 0 | 0 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Combines 7 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.”): 37,755,432 for, 2,034,622 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(b) Voyager's stockholders approved a non-binding, advisory proposal regarding the compensation of Voyager's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of VOYAGER THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on pay” (2 managers, 500 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 0 | 841,759 | 0 | 0 | Against |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 0 | 130,899 | 0 | 0 | Against |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 83,181 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 48,265 | 0 | Abstain |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 34,100 | 5,237 | 0 | 0 | Mixed |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 33,263 | 1,361 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 0 | 12,240 | 0 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 7,668,693 for, 1,083,546 against, 60,505 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,442,185 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 3,917,546 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 2,570,700 | 0 | 0 | 0 | For |
| BlackRock | 1,499,489 | 522 | 0 | 0 | For |
| Erste Asset Management GmbH | 1,116,793 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 940,418 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 925,991 | 0 | 0 | 0 | For |
| State Street | 843,666 | 238 | 0 | 0 | For |
| T. Rowe Price | 639,715 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 626,275 | 0 | 0 | 0 | For |
| FIDUCIARY TRUST CO | 259,397 | 0 | 0 | 0 | For |
| JPMorgan | 251,968 | 0 | 0 | 0 | For |
| Northern Trust | 193,889 | 0 | 0 | 0 | For |
| Wellington | 184,176 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 183,738 | 0 | 0 | 0 | For |
| Dimensional | 0 | 140,861 | 0 | 0 | Against |
| AQR | 139,949 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 0 | 132,029 | 0 | 0 | Against |
| Nuveen | 108,789 | 0 | 0 | 0 | For |
| CAPTRUST FINANCIAL ADVISORS | 95,137 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 88,781 | 0 | 0 | Against |
| Fidelity | 86,978 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 77,231 | 0 | 0 | 0 | For |
| STRS OHIO | 75,800 | 0 | 0 | 0 | For |
Institutional-manager reports, all 112 managers: 20,001,854 for, 481,062 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.4% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
VOYAGER THERAPEUTICS INC.’s own tally for this item (“Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 48,137,216 for, 249,172 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(c) Voyager's stockholders ratified the appointment of Ernst & Young LLP as Voyager's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,037,000 | 0 | 0 | 0 | For |
| BlackRock | 2,160,123 | 0 | 0 | 0 | For |
| Fidelity | 903,204 | 0 | 0 | 0 | For |
| Dimensional | 841,759 | 0 | 0 | 0 | For |
| T. Rowe Price | 423,498 | 0 | 0 | 0 | For |
| MFS | 183,738 | 0 | 0 | 0 | For |
| Charles Schwab | 137,571 | 0 | 0 | 0 | For |
| American Century | 130,899 | 0 | 0 | 0 | For |
| TIAA | 107,849 | 0 | 0 | 0 | For |
| Equitable | 95,338 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,181 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 76,599 | 0 | 0 | 0 | For |
| WisdomTree | 57,491 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 48,265 | 0 | 0 | Against |
| Goldman Sachs | 44,721 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,337 | 0 | 0 | 0 | For |
| Allspring | 38,980 | 0 | 0 | 0 | For |
| John Hancock | 34,624 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 29,960 | 0 | 0 | 0 | For |
| Northern Trust | 28,118 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,537 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 22,320 | 0 | 0 | 0 | For |
| Brighthouse | 9,134 | 0 | 12,240 | 0 | Mixed |
| Pacific Life | 21,272 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 20,559 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 8,752,239 for, 48,265 against, 12,240 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 1,116,793 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 1,116,793 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 55,336,446 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.49% |
| 2 | BlackRock | 3.90% |
| 3 | Fidelity | 1.63% |
| 4 | Dimensional | 1.52% |
| 5 | T. Rowe Price | 0.77% |
| 6 | MFS | 0.33% |
| 7 | Charles Schwab | 0.25% |
| 8 | American Century | 0.24% |
| 9 | TIAA | 0.19% |
| 10 | Equitable | 0.17% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 8.03% |
| 2 | EcoR1 Capital, LLC | 7.08% |
| 3 | FARALLON CAPITAL MANAGEMENT LLC | 4.65% |
| 4 | BlackRock | 2.71% |
| 5 | Erste Asset Management GmbH | 2.02% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.70% |
| 7 | Vestal Point Capital, LP | 1.67% |
| 8 | State Street | 1.53% |
| 9 | T. Rowe Price | 1.16% |
| 10 | GREAT POINT PARTNERS LLC | 1.13% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 9.78% | 13F |
| Integrated Core Strategies (US) LLC | 6.03% | 13G |
| Vanguard Group | 5.80% | 13F |
| Dimensional Fund Advisors | 2.70% | 13F |
| Geode Capital | 2.00% | 13F |
| State Street | 1.63% | 13F |
| T. Rowe Price | 1.12% | 13F |
| Northern Trust | 0.74% | 13F |
| Morgan Stanley | 0.69% | 13F |
| Wellington Management | 0.46% | 13F |
Percentages above are of 55,336,446 shares outstanding, as reported by VOYAGER THERAPEUTICS INC. on its Form 10-Q dated May 1, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VOYAGER THERAPEUTICS INC.’s 10-Q dated May 1, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At VOYAGER THERAPEUTICS INC.'s shareholder meeting held June 3, 2025, in the 2024-2025 proxy season, 146 asset managers reported how they voted on 8 ballot items in their SEC Form N-PX filings, covering 1,300 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of the Company's named executive… — VOYAGER THERAPEUTICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VOYAGER THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.
VOYAGER THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.